scholarly article | Q13442814 |
P50 | author | Alison M Michie | Q38321055 |
Emilio Cosimo | Q53114532 | ||
Alison M McCaig | Q114443937 | ||
P2093 | author name string | Michael T Leach | |
P2860 | cites work | Chronic lymphocytic leukemia | Q28236621 |
Phase I study of the heat shock protein 90 inhibitor alvespimycin (KOS-1022, 17-DMAG) administered intravenously twice weekly to patients with acute myeloid leukemia | Q28271726 | ||
Geldanamycin-induced Lyn dissociation from aberrant Hsp90-stabilized cytosolic complex is an early event in apoptotic mechanisms in B-chronic lymphocytic leukemia | Q30157536 | ||
Differential heat shock protein localization in chronic lymphocytic leukemia | Q33694521 | ||
Chronic lymphocytic leukemia B cells contain anomalous Lyn tyrosine kinase, a putative contribution to defective apoptosis | Q33714786 | ||
In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells | Q33830733 | ||
17-DMAG targets the nuclear factor-kappaB family of proteins to induce apoptosis in chronic lymphocytic leukemia: clinical implications of HSP90 inhibition | Q33997214 | ||
Chronic lymphocytic leukemia: revelations from the B-cell receptor. | Q35667038 | ||
B cell antigen receptor signaling 101. | Q35818846 | ||
ZAP-70 is a novel conditional heat shock protein 90 (Hsp90) client: inhibition of Hsp90 leads to ZAP-70 degradation, apoptosis, and impaired signaling in chronic lymphocytic leukemia | Q35848258 | ||
The Btk tyrosine kinase is a major target of the Bcr-Abl inhibitor dasatinib | Q35925610 | ||
Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. | Q36369648 | ||
ITAM-mediated tonic signalling through pre-BCR and BCR complexes | Q36430140 | ||
SYK-dependent tonic B-cell receptor signaling is a rational treatment target in diffuse large B-cell lymphoma | Q36445884 | ||
ZAP-70 enhances IgM signaling independent of its kinase activity in chronic lymphocytic leukemia | Q36478480 | ||
Microenvironmental influences in chronic lymphocytic leukaemia: the role of antigen stimulation | Q37328562 | ||
Heat shock protein 90 as a drug target: some like it hot. | Q37360814 | ||
Primary del 17 chronic lymphocytic leukaemia lymphocytes are hypersensitive to dasatinib in vitro | Q37413891 | ||
The microenvironment in mature B-cell malignancies: a target for new treatment strategies | Q37563816 | ||
Interaction with Vascular Endothelium Enhances Survival in Primary Chronic Lymphocytic Leukemia Cells via NF-κB Activation andDe novoGene Transcription | Q39663702 | ||
Therapeutic implications of Src independent calcium mobilization in diffuse large B-cell lymphoma | Q39798863 | ||
Spleen tyrosine kinase is overexpressed and represents a potential therapeutic target in chronic lymphocytic leukemia. | Q39834162 | ||
Tyrosine kinase inhibition in diffuse large B-cell lymphoma: molecular basis for antitumor activity and drug resistance of dasatinib. | Q39965971 | ||
The Akt/Mcl-1 pathway plays a prominent role in mediating antiapoptotic signals downstream of the B-cell receptor in chronic lymphocytic leukemia B cells | Q40069478 | ||
A sustained activation of PI3K/NF-kappaB pathway is critical for the survival of chronic lymphocytic leukemia B cells. | Q40549559 | ||
Inhibition of constitutive and BCR-induced Syk activation downregulates Mcl-1 and induces apoptosis in chronic lymphocytic leukemia B cells | Q42446777 | ||
Activities of SYK and PLCgamma2 predict apoptotic response of CLL cells to SRC tyrosine kinase inhibitor dasatinib. | Q43196182 | ||
Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia | Q44189675 | ||
Geldanamycin and herbimycin A induce apoptotic killing of B chronic lymphocytic leukemia cells and augment the cells' sensitivity to cytotoxic drugs | Q44630309 | ||
Discovery of N-(2-chloro-6-methyl- phenyl)-2-(6-(4-(2-hydroxyethyl)- piperazin-1-yl)-2-methylpyrimidin-4- ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src/Abl kinase inhibitor with potent antitumor activity in preclinical assays. | Q45198729 | ||
The tyrosine kinase Syk regulates the survival of chronic lymphocytic leukemia B cells through PKCdelta and proteasome-dependent regulation of Mcl-1 expression. | Q45937702 | ||
The novel nuclear factor-kappaB inhibitor LC-1 is equipotent in poor prognostic subsets of chronic lymphocytic leukemia and shows strong synergy with fludarabine | Q46195227 | ||
c-Abl kinase inhibitors overcome CD40-mediated drug resistance in CLL: implications for therapeutic targeting of chemoresistant niches | Q46363638 | ||
The kinase inhibitor dasatinib induces apoptosis in chronic lymphocytic leukemia cells in vitro with preference for a subgroup of patients with unmutated IgVH genes | Q46542604 | ||
Hsp90 inhibition has opposing effects on wild-type and mutant p53 and induces p21 expression and cytotoxicity irrespective of p53/ATM status in chronic lymphocytic leukaemia cells | Q46914766 | ||
Rituximab and 17-allylamino-17-demethoxygeldanamycin induce synergistic apoptosis in B-cell chronic lymphocytic leukaemia | Q46940974 | ||
CD154 induces a switch in pro-survival Bcl-2 family members in chronic lymphocytic leukaemia. | Q53531377 | ||
Separate cell culture conditions to promote proliferation or quiescent cell survival in chronic lymphocytic leukemia. | Q53534107 | ||
Survival response to B-cell receptor ligation is restricted to progressive chronic lymphocytic leukemia cells irrespective of Zap70 expression. | Q53610680 | ||
c-Abl Expression in Chronic Lymphocytic Leukemia Cells: Clinical and Therapeutic Implications | Q57374736 | ||
Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemia | Q58042064 | ||
Dasatinib sensitizes primary chronic lymphocytic leukaemia lymphocytes to chlorambucil and fludarabinein vitro | Q58436764 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | dasatinib | Q419940 |
leukemia | Q29496 | ||
lymphocyte | Q715347 | ||
chronic lymphocytic leukemia | Q1088156 | ||
dasatinib monohydrate | Q27139135 | ||
P304 | page(s) | 199-211 | |
P577 | publication date | 2011-02-24 | |
P1433 | published in | British Journal of Haematology | Q4970200 |
P1476 | title | Dasatinib inhibits B cell receptor signalling in chronic lymphocytic leukaemia but novel combination approaches are required to overcome additional pro-survival microenvironmental signals | |
P478 | volume | 153 |